{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T18:10:52Z","timestamp":1784052652260,"version":"3.55.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,14]]},"DOI":"10.7759\/cureus.112660","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T17:39:59Z","timestamp":1784050799000},"source":"Crossref","is-referenced-by-count":0,"title":["Early-Onset Hemophagocytic Lymphohistiocytosis and Inflammatory Neurotoxicity Prior to Post-transplant Cyclophosphamide: A Report of Two Cases"],"prefix":"10.7759","author":[{"given":"Kashish","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian C","family":"Betts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco L","family":"Davila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shernan","family":"Holtan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1396490","article-title":"Mechanisms and management of CAR T toxicity","volume":"14","author":"Ferreri CJ","year":"2024","unstructured":"Ferreri CJ, Bhutani M. Mechanisms and management of CAR T toxicity. Front Oncol. 2024, 14:1396490. 10.3389\/fonc.2024.1396490","journal-title":"Front Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2314005","article-title":"Hemophagocytic lymphohistiocytosis","volume":"392","author":"Henter JI","year":"2025","unstructured":"Henter JI. Hemophagocytic lymphohistiocytosis. N Engl J Med. 2025, 392:584-98. 10.1056\/NEJMra2314005","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-019-0637-7","article-title":"Haemophagocytic lymphohistiocytosis (HLH) following allogeneic haematopoietic stem cell transplantation (HSCT)-time to reappraise with modern diagnostic and treatment strategies?","volume":"55","author":"Sandler RD","year":"2020","unstructured":"Sandler RD, Carter S, Kaur H, Francis S, Tattersall RS, Snowden JA. Haemophagocytic lymphohistiocytosis (HLH) following allogeneic haematopoietic stem cell transplantation (HSCT)-time to reappraise with modern diagnostic and treatment strategies?. Bone Marrow Transplant. 2020, 55:307-16. 10.1038\/s41409-019-0637-7","journal-title":"Bone Marrow Transplant"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.23384","article-title":"Hemophagocytic lymphohistiocytosis after hematopoietic stem cell transplantation in children: a nationwide survey in Japan","volume":"59","author":"Asano T","year":"2012","unstructured":"Asano T, Kogawa K, Morimoto A, et al.. Hemophagocytic lymphohistiocytosis after hematopoietic stem cell transplantation in children: a nationwide survey in Japan. Pediatr Blood Cancer. 2012, 59:110-4. 10.1002\/pbc.23384","journal-title":"Pediatr Blood Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13174","article-title":"Post-hematopoietic stem cell transplant hemophagocytic lymphohistiocytosis or an impostor: case report and review of literature","volume":"22","author":"Vatsayan A","year":"2018","unstructured":"Vatsayan A, Pateva I, Cabral L, Dalal J, Abu-Arja R. Post-hematopoietic stem cell transplant hemophagocytic lymphohistiocytosis or an impostor: case report and review of literature. Pediatr Transplant. 2018, 22:e13174. 10.1111\/petr.13174","journal-title":"Pediatr Transplant"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2013.06.053","article-title":"Hemophagocytic lymphohistiocytosis: advances in pathophysiology, diagnosis, and treatment","volume":"163","author":"Chandrakasan S","year":"2013","unstructured":"Chandrakasan S, Filipovich AH. Hemophagocytic lymphohistiocytosis: advances in pathophysiology, diagnosis, and treatment. J Pediatr. 2013, 163:1253-9. 10.1016\/j.jpeds.2013.06.053","journal-title":"J Pediatr"},{"key":"ref7","article-title":"Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies","volume":"100","author":"Lehmberg K","year":"2015","unstructured":"Lehmberg K, Nichols KE, Henter JI, et al.. Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies. Haematologica. 2015, 100:997-1004.","journal-title":"Haematologica"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-020-01258-z","article-title":"Post-transplant hemophagocytic lymphohistiocytosis in benign hematological disorders: experience of 4 cases with review of literature","volume":"36","author":"Garg A","year":"2020","unstructured":"Garg A, Shah S, Patel K, et al.. Post-transplant hemophagocytic lymphohistiocytosis in benign hematological disorders: experience of 4 cases with review of literature. Indian J Hematol Blood Transfus. 2020, 36:674-9. 10.1007\/s12288-020-01258-z","journal-title":"Indian J Hematol Blood Transfus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-911X(199705)28:5%3C342::AID-MPO3%3E3.0.CO;2-H","article-title":"HLH- 94: a treatment protocol for hemophagocytic lymphohistiocytosis","volume":"28","author":"Henter JI","year":"1997","unstructured":"Henter JI, Aric\u00f2 M, Egeler RM, et al.. HLH- 94: a treatment protocol for hemophagocytic lymphohistiocytosis. Med Pediatr Oncol. 1997, 28:342-7. 10.1002\/(SICI)1096-911X(199705)28:5%3C342::AID-MPO3%3E3.0.CO;2-H","journal-title":"Med Pediatr Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019002289","article-title":"Emapalumab for the treatment of relapsed\/refractory hemophagocytic lymphohistiocytosis","volume":"134","author":"Vallurupalli M","year":"2019","unstructured":"Vallurupalli M, Berliner N. Emapalumab for the treatment of relapsed\/refractory hemophagocytic lymphohistiocytosis. Blood. 2019, 134:1783-6. 10.1182\/blood.2019002289","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.614704","article-title":"Use of the JAK inhibitor ruxolitinib in the treatment of hemophagocytic lymphohistiocytosis","volume":"12","author":"Keenan C","year":"2021","unstructured":"Keenan C, Nichols KE, Albeituni S. Use of the JAK inhibitor ruxolitinib in the treatment of hemophagocytic lymphohistiocytosis. Front Immunol. 2021, 12:614704. 10.3389\/fimmu.2021.614704","journal-title":"Front Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-02878-7","article-title":"IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome","volume":"24","author":"Dufranc E","year":"2020","unstructured":"Dufranc E, Del Bello A, Belliere J, Kamar N, Faguer S. IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome. Crit Care. 2020, 24:166. 10.1186\/s13054-020-02878-7","journal-title":"Crit Care"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.12.632","article-title":"Neurologic complications after allogeneic hematopoietic stem cell transplantation","volume":"23","author":"Maffini E","year":"2017","unstructured":"Maffini E, Festuccia M, Brunello L, Boccadoro M, Giaccone L, Bruno B. Neurologic complications after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2017, 23:388-97. 10.1016\/j.bbmt.2016.12.632","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.50909","article-title":"Neurologic complications after allogeneic transplantation: a meta-analysis","volume":"6","author":"Gavriilaki M","year":"2019","unstructured":"Gavriilaki M, Mainou M, Gavriilaki E, et al.. Neurologic complications after allogeneic transplantation: a meta-analysis. Ann Clin Transl Neurol. 2019, 6:2037-47. 10.1002\/acn3.50909","journal-title":"Ann Clin Transl Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.05.024","article-title":"Noninfectious neurologic complications after allogeneic hematopoietic stem cell transplantation","volume":"25","author":"Balaguer-Rosello A","year":"2019","unstructured":"Balaguer-Rosello A, Bataller L, Pi\u00f1ana JL, et al.. Noninfectious neurologic complications after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2019, 25:1818-24. 10.1016\/j.bbmt.2019.05.024","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1642583","article-title":"Cytokine release syndrome after allogeneic hematopoietic stem cell transplantation using posttransplant cyclophosphamide: current understanding and management","volume":"17","author":"Wang J","year":"2026","unstructured":"Wang J, Arora K, de Lima M. Cytokine release syndrome after allogeneic hematopoietic stem cell transplantation using posttransplant cyclophosphamide: current understanding and management. Front Immunol. 2026, 17:1642583. 10.3389\/fimmu.2026.1642583","journal-title":"Front Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/501083-early-onset-hemophagocytic-lymphohistiocytosis-and-inflammatory-neurotoxicity-prior-to-post-transplant-cyclophosphamide-a-report-of-two-cases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T17:40:00Z","timestamp":1784050800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/501083-early-onset-hemophagocytic-lymphohistiocytosis-and-inflammatory-neurotoxicity-prior-to-post-transplant-cyclophosphamide-a-report-of-two-cases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.112660","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,14]]}}}